Abbott makes Next Spine acquisition in France
This article was originally published in Clinica
Abbott Laboratories has made its second acquisition in the high-growth spinal surgery segment, with the $60m purchase of Spine Next, of Bordeaux, France. The company first entered the market in June 2003, when it paid $170m for Spinal Concepts, of Austin, Texas.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.